Pazolong 200mg Tablet
Marketer
MSN Laboratories
Salt Composition
Pazopanib (200mg)
Overview Pazolong 200mg Tablet
KinaseGuard 200mg tablets inhibit protein kinase activity, offering a treatment option for kidney cancer and soft tissue sarcoma. Administer KinaseGuard 200mg on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; improper usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include elevated blood pressure and diarrhea. Your physician might recommend regular blood pressure monitoring. Manage diarrhea with increased hydration; consult your doctor if it persists. This medication can lower blood cell counts, increasing infection risk; report fever, flu-like symptoms, or breathing difficulties immediately. Inform your doctor of any pre-existing heart, liver, or kidney conditions, and all other medications, including antibiotics, as interactions are possible. Avoid pregnancy during treatment; both partners should use reliable contraception.
Primary Ingredients of Pazolong 200mg Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Pazolong 200mg Tablet
Renal cell carcinoma and soft tissue sarcoma.
Major Benefits of Pazolong 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 200mg Pazolong tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
Common Side effects of Pazolong 200mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazolong 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 200mg Pazolong tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Pazolong 200mg Tablet works:
Pazolong 200mg tablets are an anticancer drug that targets tyrosine kinase enzyme receptors. By binding to these receptors, it blocks their activity, thus hindering the uncontrolled multiplication of cancer cells. Additionally, it prevents the formation of new blood vessels supplying the tumor, further limiting its growth and spread.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazolong 200mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Pazolong 200mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Seek medical advice before use.
Breast feedingUNSAFE
Administering Pazolong 200mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking a 200mg Pazolong tablet, as these side effects can impair alertness.
KidneySAFE IF PRESCRIBED
Pazolong 200mg tablets can be administered safely to individuals with kidney impairment. No alteration of the Pazolong 200mg tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Pazolong 200mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Pazolong 200mg tablets are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pazolong 200mg Tablet :
NA
Facts to Know About Pazolong 200mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently